Moderna’s COVID vaccine trial data shows 94% efficacy
New York: US biotech firm Moderna Inc on Monday said preliminary data from a continuing phase three study of its experimental COVID-19 vaccine showed it to be 94.5 percent effective.
“This is a pivotal moment in the development of our…